Literature DB >> 9420666

The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy.

R S Beanlands1, W F Armstrong, R J Hicks, J Nicklas, C Moore, G D Hutchins, H G Wolpers, M Schwaiger.   

Abstract

METHODS AND
RESULTS: With echocardiography and dynamic carbon 11-labeled acetate (C-11 acetate) positron emission tomographic imaging, C-11 acetate kinetics and a parameter that estimates mechanical ventricular efficiency (the work metabolic index) were defined in eight patients with dilated cardiomyopathy. The effect of afterload reduction with nitroprusside on these parameters was evaluated in six of these patients. Nitroprusside increased stroke work index but decreased the C-11 clearance rate. The work metabolic index determined noninvasively increased and correlated well with an invasive approach. The work metabolic index was inversely correlated with systemic vascular resistance. Nitroprusside shifted this relationship upward and to the left.
CONCLUSION: This method of estimating efficiency is feasible and may represent a unique noninvasive approach for the evaluation of cardiac performance and responses to therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9420666     DOI: 10.1007/bf02940007

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  44 in total

1.  Effects of insulin and starvation on the metabolism of acetate and pyruvate by the perfused rat heart.

Authors:  J R Williamson
Journal:  Biochem J       Date:  1964-10       Impact factor: 3.857

2.  Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

3.  Mechanical efficiency of the left ventricle as a function of preload, afterload, and contractility.

Authors:  H Suga; Y Igarashi; O Yamada; Y Goto
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

4.  A critical look at currently used indirect indices of myocardial oxygen consumption.

Authors:  D Baller; H J Bretschneider; G Hellige
Journal:  Basic Res Cardiol       Date:  1981 Mar-Apr       Impact factor: 17.165

5.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

Authors:  M Brown; D R Marshall; B E Sobel; S R Bergmann
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

6.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

7.  How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

8.  Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.

Authors:  A M Katz
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

Review 9.  Changing strategies in the management of heart failure.

Authors:  A M Katz
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

10.  Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

Authors:  C S Liang; L G Sherman; J U Doherty; K Wellington; V W Lee; W B Hood
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

View more
  12 in total

1.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 2.  Imaging of myocardial metabolism.

Authors:  Pilar Herrero; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

3.  PET-based myocardial efficiency: Powerful yet under-utilized-now simpler than ever.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2018-08-10       Impact factor: 5.952

4.  Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.

Authors:  Marvin W Kronenberg; Gerald I Cohen; Marlo F Leonen; Thomas A Mladsi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

5.  Evaluation of ECG-gated [(11)C]acetate PET for measuring left ventricular volumes, mass, and myocardial external efficiency.

Authors:  Nils Henrik Hansson; Lars Tolbod; Hendrik Johannes Harms; Henrik Wiggers; Won Yong Kim; Esben Hansen; Tomas Zaremba; Jørgen Frøkiær; Steen Jakobsen; Jens Sørensen
Journal:  J Nucl Cardiol       Date:  2016-04-19       Impact factor: 5.952

6.  Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Henry Ooi; Douglas B Sawyer; Mark A Lawson; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2013-10-29       Impact factor: 5.712

7.  An approach to ventricular efficiency by use of carbon 11-labeled acetate and positron emission tomography.

Authors:  H G Wolpers; A Buck; N Nguyen; P A Marcowitz; W F Armstrong; M R Starling; R Hicks; T J Mangner; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

8.  Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.

Authors:  K J Mather; G D Hutchins; K Perry; W Territo; R Chisholm; A Acton; B Glick-Wilson; R V Considine; S Moberly; T R DeGrado
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

Review 9.  Imaging of Myocardial Oxidative Metabolism in Heart Failure.

Authors:  Masanao Naya; Nagara Tamaki
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

Review 10.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.